Therapeutic Symptomatic Strategies in the Parasomnias

Therapeutic Symptomatic Strategies in the Parasomnias Purpose of review The purpose of this review was to discuss the currently available pharmacologic and non-pharmacologic treatment options for parasomnias. Recent findings Recent pathophysiological findings about sleep structure in parasomnias helped understanding several drug mechanisms of action. Serotoninergic theory accounts for the effect of serotoninergic drugs. Study about spectral analysis of sleep showed the effect of clonazepam on spectral bands. Cannabinoids proved to be effective in some of parasomnias, as in many other neurological disorders. Summary A series of therapeutic strategies were analyzed and compared. Benzodiaze- pines, antidepressant drugs, and L-5-hydroxytryptophan may be beneficial in DOA. SSRI and topiramate are effective in SRED. RBD responds to clonazepam, melatonin, and to a lesser extent to dopaminergic and anticholinergic agents. Prazosin and cannabinoids are effective in nightmare disorder. Sleep paralysis may respond to antidepressant agents. Tricyclic antidepressant may be effective in sleep-related hallucinations and exploding head syndrome. Sleep enuresis may be successfully treated with desmopressin, anticho- linergic drugs, and imipramine. Introduction Parasomnias are disorders characterized by complex On the basis of the sleep stage the parasomnias arise motor or behavioral events that occur during entry into from, they are classified as follows: NREM-related sleep, within sleep, or during arousal from http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Treatment Options in Neurology Springer Journals

Therapeutic Symptomatic Strategies in the Parasomnias

Loading next page...
 
/lp/springer_journal/therapeutic-symptomatic-strategies-in-the-parasomnias-3poXMWibBd
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Neurology; Intensive / Critical Care Medicine; Internal Medicine; Ophthalmology; General Practice / Family Medicine; Diabetes
ISSN
1092-8480
eISSN
1534-3138
D.O.I.
10.1007/s11940-018-0508-3
Publisher site
See Article on Publisher Site

Abstract

Purpose of review The purpose of this review was to discuss the currently available pharmacologic and non-pharmacologic treatment options for parasomnias. Recent findings Recent pathophysiological findings about sleep structure in parasomnias helped understanding several drug mechanisms of action. Serotoninergic theory accounts for the effect of serotoninergic drugs. Study about spectral analysis of sleep showed the effect of clonazepam on spectral bands. Cannabinoids proved to be effective in some of parasomnias, as in many other neurological disorders. Summary A series of therapeutic strategies were analyzed and compared. Benzodiaze- pines, antidepressant drugs, and L-5-hydroxytryptophan may be beneficial in DOA. SSRI and topiramate are effective in SRED. RBD responds to clonazepam, melatonin, and to a lesser extent to dopaminergic and anticholinergic agents. Prazosin and cannabinoids are effective in nightmare disorder. Sleep paralysis may respond to antidepressant agents. Tricyclic antidepressant may be effective in sleep-related hallucinations and exploding head syndrome. Sleep enuresis may be successfully treated with desmopressin, anticho- linergic drugs, and imipramine. Introduction Parasomnias are disorders characterized by complex On the basis of the sleep stage the parasomnias arise motor or behavioral events that occur during entry into from, they are classified as follows: NREM-related sleep, within sleep, or during arousal from

Journal

Current Treatment Options in NeurologySpringer Journals

Published: Jun 5, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off